U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 37 results

Status:
US Approved Rx (2007)
First approved in 2007

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Ixabepilone is an antineoplastic agent, epothilone and mitotic inhibitor that is FDA approved for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a taxane, or whose cancer i...
Status:
US Approved Rx (2017)
First approved in 2006

Class (Stereo):
CHEMICAL (ABSOLUTE)



Decitabine was first synthesized by Pliml and Sorm in the Institute of Organic Chemistry, Czechoslovak Academy of Sciences in 1964. Later, the drug was approved by FDA for the treatment of myelodysplastic syndromes in patients with cancer. Upon admin...
Status:
US Approved Rx (2001)
First approved in 2001

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dutasteride is a synthetic 4-azasteroid compound that is a selective inhibitor of both the type 1 and type 2 isoforms of steroid 5 alpha-reductase (5AR), intracellular enzymes that convert testosterone to 5 alpha-dihydrotestosterone (DHT). Type I 5a-...
Status:
US Approved Rx (2018)
First approved in 1997

Class (Stereo):
CHEMICAL (ACHIRAL)



Toremifene is an antineoplastic hormonal agent primarily used in the treatment of advanced breast cancer. Toremifene is a nonsteroidal agent that has demonstrated potent antiestrogenic properties in animal test systems. The antiestrogenic effects may...
Status:
US Approved Rx (2000)
First approved in 1993

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cladribine is used for the treatment of hairy cell leukemia and multiple sclerosis (MS). As a purine analog, it is a synthetic anti-cancer agent that also suppresses the immune system. Chemically, it mimics the nucleoside adenosine and thus inhibits ...
Status:
US Approved Rx (2007)
First approved in 1991

Class (Stereo):
CHEMICAL (ABSOLUTE)



Histrelin is a gonadotropin releasing hormone (GnRH) agonist that acts as a potent inhibitor of gonadotropin when administered as an implant that delivers continuous therapeutic doses. Following an initial stimulatory phase with increased circulating...
Status:
US Approved Rx (1991)
First approved in 1991

Class (Stereo):
CHEMICAL (ABSOLUTE)



Pentostatin, also known as 2’-deoxycoformycin (DCF) under the trade name Nipent, is a potent inhibitor of the enzyme adenosine deaminase and is isolated from fermentation cultures of Streptomyces antibioticus. It was developed by Parke-Davis (now Pfi...
Status:
US Approved Rx (1990)
First approved in 1990

Class (Stereo):
CHEMICAL (ABSOLUTE)



Nafarelin acetate (brand name Synarel) is a synthetic agonist of gonadotrophin-releasing hormone (GnRH) [luteinising hormone-releasing hormone (LH-RH), which is indicated for management of endometriosis, including pain relief and reduction of endomet...
Status:
US Approved Rx (1991)
First approved in 1971

Class (Stereo):
CHEMICAL (ABSOLUTE)



Minocycline is a tetracycline analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant staphylococcus infections. Minocycline has many brand names one of them is minocin, Minocin...
Status:
US Approved Rx (1997)
First approved in 1971

Class (Stereo):
CHEMICAL (ACHIRAL)



Alitretinoin, or 9-cis-retinoic acid, is a form of vitamin A. It is also used in medicine as an antineoplastic (anti-cancer) agent developed by Ligand Pharmaceuticals. Alitretinoin (9-cis-retinoic acid) is a naturally-occurring endogenous retinoid in...